<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Height outcomes for growth hormone treatment in children with idiopathic short stature (selected studies)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Height outcomes for growth hormone treatment in children with idiopathic short stature (selected studies)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Height outcomes for growth hormone treatment in children with idiopathic short stature (selected studies)</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Study</td> <td class="subtitle1">Mean height gain</td> <td class="subtitle1">Duration of therapy (mean)</td> <td class="subtitle1">Adult height reported</td> <td class="subtitle1">Comment</td> </tr> <tr class="divider_bottom"> <td>Finkelstein 2002<sup>[1]</sup><br/> (meta-analysis)</td> <td>4 to 6 cm</td> <td>5.3 years</td> <td class="centered">Yes</td> <td> <p>Short stature defined as stature &lt;10<sup>th</sup> percentile.</p> Large number of patients: 1089. </td> </tr> <tr class="divider_bottom"> <td>Deodati 2011<sup>[2]</sup><br/> (meta-analysis)</td> <td>4.7 cm</td> <td>5.4 years</td> <td class="centered">Yes</td> <td> <p>Small number of patients: 115.</p> Only randomized trials were included. </td> </tr> <tr class="divider_bottom"> <td>Counts 2015<sup>[3]</sup><br/> (randomized controlled trial)</td> <td>1.3 SDS (approximately 8 cm)</td> <td>4 years</td> <td class="centered">No</td> <td> <p>Height gain calculated by the height SDS change from baseline to the end of the study (2 to 4 years). Height gain was similar for both treatment groups.</p> Randomization was to compare 2 different treatment regimens rather than to compare growth hormone with an untreated control group. </td> </tr> <tr> <td>Child 2019<sup>[4]</sup><br/> (prospective observational study)</td> <td> <p>8 cm after 4.6 years</p> 10 cm after 6.5 years</td> <td>6.5 years</td> <td class="centered">Yes</td> <td> <p>Many patients with delayed bone age were included.</p> Spontaneous catch-up growth may have contributed to the height gain reported. </td> </tr> </tbody></table></div><div class="graphic_lgnd">In this table, height gain refers to the estimated gain in adult height attributable to growth hormone therapy. Note that these are mean outcomes for the study,and do not capture the wide interindividual variation in response to growth hormone therapy; some patients experience no increase in adult height attributable to growth hormone treatment. In most of these studies, height gain was calculated from the difference between adult height (or near-adult height) at the end of treatment compared with predicted adult height at baseline, irrespective of age. An exception is that, for Counts<sup>[3]</sup>, height gain was calculated by the height SDS change from baseline to the end of the study (2 to 4 years).</div><div class="graphic_footnotes">SD: standard deviation score.</div><div class="graphic_reference">References:

	<ol>
<li>Finkelstein BS, Imperiale TF, Speroff T, et al. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 2002; 156:230.</li>
<li>Deodati A, Cianfarani S. Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review. BMJ 2011; 342:c7157.</li>
<li>Counts DR, Silverman LA, Rajicic N, et al. A 4-Year, Open-Label, Multicenter, Randomized Trial of GenotropinÂ® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety Between an Individualized, Target-Driven Regimen and Standard Dosing. Horm Res Paediatr 2015; 84:79.</li>
<li>Child CJ, Quigley CA, Cutler GB Jr, et al. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study. Horm Res Paediatr 2019; 91:241.</li>
</ol></div><div id="graphicVersion">Graphic 128199 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
